SCHEMBL19924461

SCHEMBL19924461

CC1CC[C@@H](C)CC(Cl)C1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38
TRPA1 O75762 2/20 0.35
TRPM8 Q7Z2W7 2/20 0.35
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18411736 0.91 L3MBTL1 (0.33) L3MBTL1TRPA1TRPM8EPHX1
SCHEMBL18611198 0.90
SCHEMBL7363310 0.90
SCHEMBL685314 0.90
SCHEMBL18611197 0.90
SCHEMBL18752288 0.87 CYP2C9 (0.32)
SCHEMBL27844011 0.87
SCHEMBL8604797 0.85
SCHEMBL24649615 0.81
SCHEMBL4394617 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018039518-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-01 WO disclosed